These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10102487)

  • 1. Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis?
    Ferroni P; Pulcinelli FM; Lenti L; Gazzaniga PP
    Thromb Haemost; 1999 Mar; 81(3):472-3. PubMed ID: 10102487
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble P-selectin as parameter for platelet activation during storage.
    Kostelijk EH; Fijnheer R; Nieuwenhuis HK; Gouwerok CW; de Korte D
    Thromb Haemost; 1996 Dec; 76(6):1086-9. PubMed ID: 8972035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT).
    Jy W; Mao WW; Horstman LL; Valant PA; Ahn YS
    Thromb Haemost; 1999 Oct; 82(4):1255-9. PubMed ID: 10544909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function.
    Leinoe EB; Hoffmann MH; Kjaersgaard E; Nielsen JD; Bergmann OJ; Klausen TW; Johnsen HE
    Br J Haematol; 2005 Feb; 128(4):526-32. PubMed ID: 15686463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.
    Lim YA; Cho SR; Lee WG; Park JS; Kim SW
    Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
    Wang J; Cao L; He M
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of activated platelets in canine blood by use of flow cytometry.
    Wills TB; Wardrop KJ; Meyers KM
    Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
    Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia.
    Leinoe EB; Hoffmann MH; Kjaersgaard E; Johnsen HE
    Br J Haematol; 2004 Oct; 127(1):76-84. PubMed ID: 15384980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles.
    Pearson L; Thom J; Adams M; Oostryck R; Krueger R; Yong G; Baker R
    Int J Lab Hematol; 2009 Aug; 31(4):430-9. PubMed ID: 18384393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formation.
    Dunkel B; Rickards KJ; Werling D; Page CP; Cunningham FM
    Vet Immunol Immunopathol; 2009 Sep; 131(1-2):25-32. PubMed ID: 19362377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reliable plasma marker of platelet activation: does it exist?
    Gurney D; Lip GY; Blann AD
    Am J Hematol; 2002 Jun; 70(2):139-44. PubMed ID: 12111787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombogenesis in sickle cell disease.
    Tomer A; Harker LA; Kasey S; Eckman JR
    J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking and characterisation of transfused platelets by two colour, whole blood flow cytometry.
    Hughes DL; Evans G; Metcalfe P; Goodall AH; Williamson LM
    Br J Haematol; 2005 Sep; 130(5):791-4. PubMed ID: 16115139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations.
    Leytin V; Mody M; Semple JW; Garvey B; Freedman J
    Biochem Biophys Res Commun; 2000 Mar; 269(1):85-90. PubMed ID: 10694482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia.
    Panzer S; Höcker L; Vormittag R; Rieger M; Koren D; Dunkler D; Pabinger I
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):694-6. PubMed ID: 16933254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.